Search alternatives:
significant values » significant value (Expand Search), significant advances (Expand Search), significant changes (Expand Search)
values based » value based (Expand Search), values used (Expand Search), values ranged (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant values » significant value (Expand Search), significant advances (Expand Search), significant changes (Expand Search)
values based » value based (Expand Search), values used (Expand Search), values ranged (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
170
Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
171
Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
172
Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
173
Data_Sheet_1_A de novo Mutation in the MTUS1 Gene Decreases the Risk of Non-compaction of Ventricular Myocardium via the Rac1/Cdc42 Pathway.pdf
Published 2019“…The phosphorylation of Rac1/Cdc42 in the mutation group was significantly lower than in the wild type group.</p><p>Conclusions: A de novo mutation in MTUS1 decreased the stability of microtubules and increased cell polarity via the Rac1/Cdc42 pathway, which may partly elucidate the mechanism underlying cellular protection in NVM.…”
-
174
-
175
The number of gauging cross-sections where a statistically significant decreasing trend was identified.
Published 2024“…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.…”
-
176
Global Moran’s I statistics and significance test value based on different proximity.
Published 2021“…<p>Global Moran’s I statistics and significance test value based on different proximity.…”
-
177
-
178
DataSheet_1_Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cance...
Published 2023“…Patients with decreased MLR had a significantly higher ORR in the univariate (P<0.001) and multivariate (P<0.001) Cox proportional hazards models. …”
-
179
-
180
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…In the non-recurrence group, visits declined from 10.4 ± 4.5 preoperatively to 7.1 ± 2.2, 3.4 ± 1.3, and 2.6 ± 1.0 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g008" target="_blank">Fig 8</a>).…”